Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Kurita, Masatake ^a,b   Nishino, Satoshi ^a,b   Kato, Maiko ^a   Numata, Yukio ^a   Sato, Tadahiro ^a  

^a Koutokukai   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ARIPIPRAZOLE; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CHINESE DRUG; CLOMIPRAMINE; FLUVOXAMINE; HANGE KOBUKU TO; IMIPRAMINE; MAPROTILINE; MILNACIPRAN; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NATURALISTIC INQUIRY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSYCHOTHERAPY; REFRACTORY PERIOD; REMISSION; SEX; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; YOUNG ADULT;

EID: 84862990970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039212     Document Type: Article

References (30)

1. Duman RS, Heninger GR, Nestler EJ, (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606.
2. Lewin GR, Barde YA, (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19: 289-317.
3. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS, (1994) Neurotrophic factors: from molecule to man. Trends Neurosci 17: 182-190.
4. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, et al. (2006) Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 30: 1256-1260.
5. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, et al. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109: 143-148.
6. Lee BH, Kim H, Park SH, Kim YK, (2007) Decreased plasma BDNF level in depressive patients. J Affect Disord 101: 239-244.
7. Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, et al. (2008) Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 105: 279-283.
8. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, et al. (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75.
9. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, et al. (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57: 1068-1072.
10. Aydemir O, Deveci A, Taneli F, (2005) The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29: 261-265.
11. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, et al. (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255: 381-386.
12. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R, (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 136: 29-37.
13. Montgomery SA, Asberg M, (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
14. Montgomery SA, Smeyatsky N, de Ruiter M, Montgomery DB, (1985) Profiles of antidepressant activity with the Montgomery-Asberg Depression Rating Scale. Acta Psychiatr Scand pp. 38-42.
15. Peyre F, Martinez R, Calache M, Verdoux H, Bourgeois M, (1989) [New validation of the Montgomery and Asberg Depression Scale (MADRS) on a sample of 147 hospitalized depressed patients]. Ann Med Psychol (Paris) 147: 762-767.
16. Maier W, Philipp M, Heuser I, Schlegel S, Buller R, et al. (1988) Improving depression severity assessment-I. Reliability, internal validity and sensitivity to change of three observer depression scales. J Psychiatr Res 22: 3-12.
17. Mittmann N, Mitter S, Borden EK, Herrmann N, Naranjo CA, et al. (1997) Montgomery-Asberg severity gradations. Am J Psychiatry 154: 1320-1321.
18. Berlim MT, Fleck MP, Turecki G, (2008) Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Ann Med 40: 149-159.
19. Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, et al. (2009) Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res 43: 247-254.
20. Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, et al. (2011) Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 16: 1088-1095.
21. Angelucci F, De Bartolo P, Gelfo F, Foti F, Cutuli D, et al. (2009) Increased concentrations of nerve growth factor and brain-derived neurotrophic factor in the rat cerebellum after exposure to environmental enrichment. Cerebellum 8: 499-506.
22. Laske C, Banschbach S, Stransky E, Bosch S, Straten G, et al. (2010) Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int J Neuropsychopharmacol 13: 595-602.
23. Sen S, Duman R, Sanacora G, (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64: 527-532.
24. Dreimuller N, Schlicht KF, Wagner S, Peetz D, Borysenko L, et al. (2011) Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology.
25. Elfving B, Plougmann PH, Muller HK, Mathe AA, Rosenberg R, et al. (2010) Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol 13: 563-572.
26. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, et al. (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87: 728-734.
27. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, et al. (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14: 347-353.
28. Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS, (2009) Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 30: 3719-3735.
29. Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, et al. (2009) Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34: 2376-2389.
30. MacQueen GM, (2009) Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. J Psychiatry Neurosci 34: 343-349.